BRCA 1 & BRCA 2

BRCA 1 & BRCA 2

The BRCA1 and BRCA2 gene testis a blood test that can determine
your likelihood of developing cancer by identifying any
possiblemutations in the BRCA1 and BRCA2 genes

● Female and male breast cancer
● Ovarian cancer (including cancer
of the fallopian tube and primary
peritoneal cancers)
● Prostate Cancer
● Pancreatic Cancer
● Melanoma

● Enhances overall survival rates by
enabling early detection through
evaluating the risk of hereditary
cancer.
● For individuals who already have
cancer and possess inherited

harmful BRCA mutations, genetic
testing supports the selection of
targeted therapy involving PARP
inhibitors. Additionally, it assists
healthcare providers in making
informed treatment decisions and
determining appropriate preventive
measures.

● A personal history of breast or
ovarian cancer diagnosed at a
young age (premenopausal),
bilateral breast cancer (affecting
both breasts), or the presence of
both ovarian and breast cancer.
● A family history of breast, ovarian,
fallopian tube, peritoneal, prostate,
or pancreatic cancer.
● A male family member having
breast cancer.
● A relative with a known deleterious
mutation in BRCA1 or BRCA2
genes.
● A history of breast/ovarian cancer
diagnosed below the age of 45
years.
● A family member with bilateral
breast cancer below the age of 50.
● Two or more relatives with ovarian
cancer.

● Breast and ovarian cancers in
either the same woman or the
same family.